Literature DB >> 31812331

Inflammatory markers in systemic lupus erythematosus.

Martin Aringer1.   

Abstract

While systemic lupus erythematosus (SLE) is an autoantibody and immune complex disease by nature, most of its organ manifestations are in fact inflammatory. SLE activity scores thus heavily rely on assessing inflammation in the various organs. This focus on clinical items demonstrates that routine laboratory markers of inflammation are still limited in their impact. The erythrocyte sedimentation rate (ESR) is used, but represents a rather crude overall measure. Anemia and diminished serum albumin play a role in estimating inflammatory activity, but both are reflecting more than one mechanism, and the association with inflammation is complex. C-reactive protein (CRP) is a better marker for infections than for SLE activity, where there is only a limited association, and procalcitonin (PCT) is also mainly used for detecting severe bacterial infection. Of the cytokines directly induced by immune complexes, type I interferons, interleukin-18 (IL-18) and tumor necrosis factor (TNF) are correlated with inflammatory disease activity. Still, precise and timely measurement is an issue, which is why they are not currently used for routine purposes. While somewhat more robust in the assays, IL-18 binding protein (IL-18BP) and soluble TNF-receptor 2 (TNF-R2), which are related to the respective cytokines, have not yet made it into clinical routine. The same is true for several chemokines that are increased with activity and relatively easy to measure, but still experimental parameters. In the urine, proteinuria leads and is essential for assessing kidney involvement, but may also result from damage. Similar to the situation in serum and plasma, several cytokines and chemokines perform reasonably well in scientific studies, but are not routine parameters. Cellular elements in the urine are more difficult to assess in the routine laboratory, where sufficient routine is not always available. Therefore, the analysis of urinary T cells may have potential for better monitoring renal inflammation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anemia; C-reactive protein; Chemokines; Cytokines; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2019        PMID: 31812331     DOI: 10.1016/j.jaut.2019.102374

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  27 in total

Review 1.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

2.  The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.

Authors:  Balaji Musunuri; Rina Tripathy; Sunali Padhi; Aditya K Panda; Bidyut K Das
Journal:  Clin Rheumatol       Date:  2022-07-14       Impact factor: 3.650

3.  Neurological Symptoms and Their Associations With Inflammatory Biomarkers in the Chronic Phase Following Traumatic Brain Injuries.

Authors:  Gangqin Li; Hao Liu; Yong He; Zeqing Hu; Yan Gu; Yan Li; Yi Ye; Junmei Hu
Journal:  Front Psychiatry       Date:  2022-06-24       Impact factor: 5.435

4.  Causal Relationship Between Sleep Traits and Risk of Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study.

Authors:  Ni Sang; Rui-Chen Gao; Meng-Yao Zhang; Zhen-Zhen Wu; Zhen-Gang Wu; Guo-Cui Wu
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 5.  Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.

Authors:  María Morell; Francisco Pérez-Cózar; Concepción Marañón
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Serum cytokines to predict systemic lupus erythematosus clinical and serological activity.

Authors:  Victor Moreno-Torres; Raquel Castejón; María Martínez-Urbistondo; Ángela Gutiérrez-Rojas; Jose Vázquez-Comendador; Pablo Tutor; Pedro Durán-Del Campo; Susana Mellor-Pita; Silvia Rosado; Juan-Antonio Vargas-Núñez
Journal:  Clin Transl Sci       Date:  2022-05-04       Impact factor: 4.438

7.  Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study.

Authors:  Bilge Sumbul; Hilmi Erdem Sumbul; Ramazan Azim Okyay; Erdinç Gülümsek; Ahmet Rıza Şahin; Baris Boral; Burhan Fatih Koçyiğit; Mostafa Alfishawy; Jeffrey Gold; Alİ Muhittin Tasdogan
Journal:  PeerJ       Date:  2021-02-09       Impact factor: 2.984

8.  Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis.

Authors:  Jozsef A Balog; Agnes Kemeny; Laszlo G Puskas; Szilard Burcsar; Attila Balog; Gabor J Szebeni
Journal:  Mediators Inflamm       Date:  2021-06-17       Impact factor: 4.711

9.  Integrated Transcriptome Profiling Revealed That Elevated Long Non-Coding RNA-AC007278.2 Expression Repressed CCR7 Transcription in Systemic Lupus Erythematosus.

Authors:  Yi You; Xingwang Zhao; Yaguang Wu; Jiangming Mao; Lan Ge; Junkai Guo; Chenglei Zhao; Dong Chen; Zhiqiang Song
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

10.  Association Between Gamma-Glutamyl Transferase, Total Bilirubin and Systemic Lupus Erythematosus in Chinese Women.

Authors:  Wenran Zhang; Zhaoyang Tang; Yanjun Shi; Long Ji; Xueyu Chen; Yanru Chen; Xiaohui Wang; Meng Wang; Wei Wang; Dong Li
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.